ArticleHealth science reports2026
Ischemic Heart Disease in the Middle East and North Africa, 1990-2021: An Integrated Analysis of Temporal Trends, Country-Level Variation, SDI Patterns, and Risk Factors.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ischemic heart disease (IHD) remains a leading cause of mortality and disability worldwide. Using Global Burden of Disease (GBD) 2021 estimates, this study provides an integrated assessment of IHD burden across the Middle East and North Africa (MENA) region from 1990 to 2021, highlighting temporal trends, inter-country heterogeneity, sociodemographic index (SDI)-related patterns, and attributable risk factors by sex and age. Methods: We conducted a secondary analysis of GBD 2021 estimates for the 21 countries and territories in MENA. We assessed prevalence, deaths, and disability-adjusted life years (DALYs), reporting counts and age-standardized rates per 100,000 population with 95% uncertainty intervals (UIs). This framework allowed direct comparison of temporal change, cross-country variation, development-related gradients, and modifiable risk attribution within a single regional analysis. Results: In 2021, the age-standardized prevalence of IHD in MENA was 6404.8 per 100,000 (95% UI: 5872.0-7041.1), with an age-standardized mortality rate of 202.8 (95% UI: 180.6-223.7) and DALY rate of 4023.2 (95% UI: 3581.7-4507.5). Although age-standardized death and DALY rates declined from 1990 to 2021, the burden remained substantial and unevenly distributed. Kuwait had the highest age-standardized prevalence [7806.4 (95% UI: 7141.6-8556.3)] and Turkey the lowest [5365.9 (95% UI: 4895.5-5874.7)]. Saudi Arabia had the largest increase in age-standardized prevalence [17.1% (95% UI: 11.4-23.0)], whereas Turkey had the largest decrease [-11.9% (95% UI: -17.3 to -6.9)]. DALY rates increased progressively with age for both sexes, and IHD burden showed an inverse, non-linear relationship with SDI. The leading contributors to IHD DALYs were elevated systolic blood pressure [49.6%], elevated LDL cholesterol [39.6%], and exposure to ambient particulate matter pollution [28.2%]. Conclusion: Despite reductions in age-standardized mortality and DALY rates, IHD remains a major public health challenge in MENA, with substantial cross-country variation and a large contribution from modifiable risks. By integrating temporal trends, inter-country heterogeneity, SDI-related patterns, and attributable risk factors, this study provides novel evidence for prioritizing prevention efforts across the region. These findings support context-specific prevention strategies prioritizing hypertension control, lipid management, and improved access to cardiovascular prevention and treatment, alongside action to reduce air pollution exposure; implementation should be tailored to national risk profiles, disease trends, and health-system capacity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.